Clear Harbor Asset Management LLC Has $7.98 Million Position in CME Group Inc. (NASDAQ:CME)

Clear Harbor Asset Management LLC raised its stake in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 0.5% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 36,171 shares of the financial services provider’s stock after buying an additional 168 shares during the period. Clear Harbor Asset Management LLC’s holdings in CME Group were worth $7,981,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the stock. Capital International Investors lifted its stake in shares of CME Group by 24.1% in the 1st quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock valued at $3,403,557,000 after purchasing an additional 3,069,806 shares during the last quarter. Ameriprise Financial Inc. lifted its stake in shares of CME Group by 11.3% in the 2nd quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock valued at $1,038,676,000 after purchasing an additional 537,758 shares during the last quarter. GUARDCAP ASSET MANAGEMENT Ltd lifted its stake in shares of CME Group by 1.1% in the 1st quarter. GUARDCAP ASSET MANAGEMENT Ltd now owns 4,009,068 shares of the financial services provider’s stock valued at $863,112,000 after purchasing an additional 43,293 shares during the last quarter. Raymond James & Associates lifted its stake in shares of CME Group by 3.2% in the 2nd quarter. Raymond James & Associates now owns 3,029,145 shares of the financial services provider’s stock valued at $595,530,000 after purchasing an additional 94,302 shares during the last quarter. Finally, Legal & General Group Plc lifted its stake in shares of CME Group by 6.6% in the 2nd quarter. Legal & General Group Plc now owns 2,835,075 shares of the financial services provider’s stock valued at $557,371,000 after purchasing an additional 176,004 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Buying and Selling at CME Group

In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the transaction, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the sale, the chief financial officer now owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.30% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on CME shares. Bank of America lifted their price objective on shares of CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a research note on Thursday, October 3rd. Keefe, Bruyette & Woods boosted their target price on shares of CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a research report on Thursday, July 25th. Piper Sandler raised their price target on CME Group from $225.00 to $240.00 and gave the company an “overweight” rating in a research report on Tuesday, October 8th. Redburn Atlantic cut CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price objective for the company. in a research report on Tuesday, October 8th. Finally, JPMorgan Chase & Co. lifted their price target on CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a research report on Thursday, July 25th. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, CME Group has an average rating of “Hold” and a consensus target price of $222.07.

Get Our Latest Research Report on CME Group

CME Group Stock Down 1.5 %

Shares of CME stock opened at $226.14 on Friday. The stock has a market cap of $81.43 billion, a P/E ratio of 25.73, a price-to-earnings-growth ratio of 7.76 and a beta of 0.55. CME Group Inc. has a one year low of $190.70 and a one year high of $230.36. The stock has a fifty day moving average price of $218.94 and a 200 day moving average price of $208.89. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CMEGet Free Report) last issued its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, topping the consensus estimate of $2.65 by $0.03. The firm had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.59 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. CME Group’s quarterly revenue was up 18.4% compared to the same quarter last year. During the same period last year, the business earned $2.25 earnings per share. Analysts predict that CME Group Inc. will post 10.04 earnings per share for the current year.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were given a $1.15 dividend. The ex-dividend date of this dividend was Monday, September 9th. This represents a $4.60 annualized dividend and a yield of 2.03%. CME Group’s dividend payout ratio (DPR) is currently 52.33%.

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Read More

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.